H1 202022 Aug 2019 14:42
This share is unloved and suffering from constant poor retail sales figures. However, it is just not retail - its DTC operation contributes a good % of the revenues and it is main product, ST, is now in c 3 times the UK stores than this time last year (2,300 v7 80) .
Profits just announced are a record c£1.4m and 2020 is forecast at £2.4m (on revenues of £13m and £15.4 m respectively).
Looking at H1 last year it was a disaster (£3.9m v £4.2 the previous year).
It would appear ST suffered due to the Superdrug exclusivity fallout and also DTC advertising issues.
These are now resolved - SD has increased shelf space by 20% and DTC had record numbers in May and June 2019.
In 2018 H1 ST accounted for c£3.8m of the £4.2m rev whereas in 2019 ST dropped to c£3m (as Roots increased substantially).
If we use the 2018 ST number for 2020 and add conservative Boots sales of £1.3m (£50 a week at 1,000 stores for 26 weeks) that £5.1m. Add Roots 0.8m (was 0.65 in H1 2019) and others 0.4m (c0.25 in 2019 but higher C+L and hopefully Prolong too) that's £6.3m - an increase of £2.4m (over 50% H1 year on year).
Now 2020 full year is only forecast to increase by £2.4m and we could get that all in H1.
Therefore, assuming July and August trading has gone ok and the trading update is reasonably positive next month I can see FinnCap revising their 2020 numbers.
All IMHO of course